Abstract
The analogues of oxytocin and [1-penicillamine]oxytocin, containing a cycloleucine (Cle) residue in position 2 or 8, were investigated by means of circular dichroism measurements in different solvents, and the results examined in terms of their biological activities. A cycloleucine residue in position 2 substantially reduces the free conformational space of the hormone 20-membered ring moiety (including the disulfide group), and stabilizes a conformation which is close to one of the possible conformations of oxytocin and involves a β-turn. In position 8, the Cle residue affects the conformation of the Tyr2 side chain, apparently forcing it away from the space above the 20-membered disulfide ring. However, it does not appear that the Cle residue has any significant effect on the overall backbone conformation of the hormone. The steric effect of the penicillamine residue in position 1 on the conformation of the disulfide group and Tyr2 side chain from previous investigations is further confirmed. The synthesis and biological potency of [1-penicillamine, 8-cycloleucine]oxytocin is described. This analogue exhibits a strong inhibitory effect on the uterotonic activity of oxytocinin vitro. It also inhibited the vasopressor response to vasopressin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benedetti, E., Barone, V., Bavoso, A., DiBlasio, B., Lelj, F., Pavone, V., Pedone, C., Toniolo, C., Crisma, M., and Bonoro, G. M. (1987). InPeptides 1986 (Theodoropoulas, D., ed.), W. de Gruyter, Berlin, pp. 315–318.
Bodanszky, M., Funk, K. W., and Fink, M. L. (1973).J. Org. Chem. 38, 3565–3572.
Chan, W. Y., Hruby, V. J., Rockway, T. W., and Hlavacek, J. (1986).J. Pharmacol. Exp. Ther. 239, 84–87.
Fric, I. (1987). InHandbook of Neurophypophyseal Hormone Analogs (Jost, K., Lebl, M., and Brtnik, F., eds.), CRC Press Inc., Boca Raton, Florida, pp. 159–211.
Fric, I., Kodicek, M., Jost, K., and Blaha, K. (1974).Collect. Czech. Chem. Commun. 39, 1271–1289.
Fric, I., Malon, P., Jost, K., and Blaha, K. (1983). InPeptides 1982. Proceedings of the 17th European Peptide Symposium (Blaha, K., and Malon, P., eds.), Walter de Gruyter, Berlin, pp. 103–116.
Hemple, J. C. (1987). InThe Peptides: Analysis, Synthesis, Biology. Vol. 8, Chemistry, Biology and Medicine of Neurophypophyseal Hormones and Their Analogues (Smith, C. W., ed.), Academic Press, New York, pp. 209–237.
Hlavacek, J., Podusaka, K., Jost, K., Fric, I., Barth, T., Cort, J. H., Blaha, K., and Sorm, F. (1977).Collect. Czech. Chem. Commun. 42, 1233–1247.
Hlavacek, J., Pospisek, J., Slaninova, J., Chan, W. Y., and Hruby, V. J. (1987).Collect. Czech. Chem. Commun. 52, 2317–2325.
Hlavacek, J. (1987). InHandbook of Neurophypophyseal Hormone Analogs (Jost, K., Lebl, M., and Brtnik, F., eds.), CRC Press, Inc., Boca Raton, Florida, pp. 228–257.
Hope, D. B., Murti, V. V. S., and du Vigneaud, V. (1962).J. Biol. Chem. 237, 1563–1566.
Hruby, V. J. (1981a). InPerspectives in Peptide Chemistry (Wieland, T., Geiger, R., and Eberle, A., eds.), Karger, Basel, pp. 207–220.
Hruby, V. J. (1981b). InTopics in Molecular Pharmacology (Burgen, A. S. V., and Roberts, G. C. K., eds.), Elsevier/North Holland, Amsterdam, pp. 99–126.
Hruby, V. J. (1982).Life Sci. 31, 189–199.
Hruby, V. J. (1985). InOxytocin: Clinical and Laboratory Studies (Amico, J. A., and Robinson, A. G., eds.), Elsevier/North Holland, New York, pp. 405–414.
Hruby, V. J., and Groginsky, C. M. (1971).J. Chromatogr. 63, 423–438.
Hruby, V. J., Deb, K. K., Fox, J., Bjarnason, J., and Tu, A. T. (1978).J. Biol. Chem. 253, 6060–6067.
Hruby, V. J., Deb., K. K., and Yamamoto, D. M. (1979).J. Med. Chem. 22, 7–12.
Hruby, V. J., and Mosberg, H. I. (1982). InHormone Antagonists (Agarwal, M. K., ed.), Walter de Gruyter and Co., Berlin, pp. 433–473.
Hruby, V. J., Rockway, T. W., Viswanatha, V., and Chan, W. Y. (1989).Int. J. Pept. Protein Res. 21, 24–34.
Hruby, V. J., and Lebl, M. (1987). InHandbook of Neurohypophyseal Hormone Analogs (Jost, K., Lebl, M., and Brtnik, F., eds.), CRC Press, Inc., Boca Raton, Florida, pp. 105–155.
Kaiser, E., Colescott, R. L., Bossinger, C. D., and Cook, P. I. (1970).Anal. Biochem. 34, 595–598.
Meraldi, J. P., Hruby, V. J., and Brewster, A. I. R. (1977).Proc. Natl. Acad. Sci. USA 74, 1373–1377.
Schild, H. O. (1947).Br. J. Pharmacol. 2, 189–206.
Wood, S. P., Tickle, I. J., Treharne, A. M., Pitts, J. E., Mascarehas, Y., Li, J. Y., Hussain, J., Cooper, S., Blundell, T. L., Hruby, V. J., Buku, A., Fischman, A. J., and Wyssbrod, H. R. (1986).Science 232, 633–636.
Woody, R. W. (1975). InPeptides, Polypeptides and Proteins (Blout, E. R., Bovey, F. A., Goodman, M., and Lotan, N., eds.), Wiley Interscience, New York, pp. 338–343.
Woody, R. W. (1985). InThe Peptides, Analysis, Synthesis, Biology, Vol. 7, Conformation in Biology and Drug Design (Hruby, V. J., ed.), Academic Press, New York, pp. 15–114.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fric, I., Hlavacek, J., Rockway, T.W. et al. Effects of conformational constraint in 2- and 8-cycloleucine analogues of oxytocin and [1-penicillamine] oxytocin examined by circular dichroism and biosassay. J Protein Chem 9, 9–15 (1990). https://doi.org/10.1007/BF01024978
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01024978